Burden of respiratory syncytial virus and influenza in adults - A Danish nationwide cohort study - PubMed
3 hours ago
- #Influenza
- #Cohort Study
- #RSV
- The study investigates the clinical and economic burden of respiratory syncytial virus (RSV) and influenza in Danish adults over a decade.
- RSV patients had higher risks of adverse outcomes like death, COPD and asthma exacerbations, sepsis, and increased healthcare resource utilization compared to unexposed individuals.
- Influenza patients also showed worse clinical and economic outcomes than unexposed peers, though with fewer comorbidities than RSV patients.
- The mean difference in direct costs was higher for RSV patients (€12,096) than for influenza patients (€7,992).
- Findings support the need for adult vaccination strategies against RSV, given its severe long-term burden comparable to influenza.